High-flow nasal oxygen therapy allows delivery of heated, humidified oxygen at flow rates of up to 60 L/min In the setting of acute respiratory failure, patients may generate inspiratory flow rates ...

High-flow nasal cannula (HFNC) oxygen therapy is a relatively recent innovation in adult critical care units. It delivers warm humidified oxygen at high flow rates (between 15 and 60 L/min) through a ...

The North America high-flow oxygen therapy devices industry is projected to attain a 29.8% value share in 2022. The United States high-flow oxygen therapy devices industry rules the North America ...

Early high-flow oxygen also nearly doubled ICU admission rates (12.5% vs 6.9%; aOR 1.93, 95% CI 1.35-2.75), which Schibler called surprising, albeit in keeping with the pilot PARIS trial of the ...

New York, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The high flow oxygen therapy devices market was worth US$ 1.7 Bn at the end of 2021, according to detailed industry analysis by Persistence Market ...

Our trial showed high-flow oxygen delivery during anesthesia for tubeless airway surgery was uninterrupted and successful in 89 per cent of cases, compared to 88 per cent of cases using standard care.

The global high flow oxygen therapy devices market was valued at US$ 1.7 billion in 2022. However, it is projected to record a negative CAGR of -2.4% from 2023 to 2031, reaching approximately US$ 1.4 ...

The global high flow oxygen therapy devices market is anticipated to witness moderate growth, rising from USD 1.3 billion in 2025 to USD 1.6 billion by 2035 at a CAGR of 2.1% over the forecast period.

The addition of high-flow nasal cannula to long-term oxygen therapy may decrease exacerbations among patients with stable hypercapnic COPD, according to a study published in American Journal of ...

Source Reference: George S, et al "Effectiveness of nasal high-flow oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and ICU settings: a randomised, controlled ...

For these outcomes, compared to conventional oxygen, high-flow oxygen was significantly associated with lower risk of intubation at day 7 (31.3% vs 50%) and day 14 (34.3% vs 51.0%), and more ...